Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.6.3 was added to the history. The previous v3.6.2 entry was removed, updating the study record's revision log.SummaryDifference0.1%

- Check18 days agoChange DetectedA new revision entry, v3.6.2, was added to the study's record history, and the older v3.6.0 entry was removed from the list.SummaryDifference0.1%

- Check33 days agoChange DetectedA new revision entry v3.6.0 was added to the study's record history, and the previous revision v3.5.5 was removed, reflecting an update to the page's versioning.SummaryDifference0.3%

- Check40 days agoChange DetectedA new revision entry v3.5.5 was added to the page's history, and the previous revision v3.5.4 was removed from the list. This updates the version history to reflect the latest revision.SummaryDifference0.1%

- Check61 days agoChange DetectedRecord History now shows a new revision entry, v3.5.4, indicating an update to the study record's revision history. The previous entry, v3.5.3, is removed from the current history view.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page footer’s system revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a platform update with no change to the study’s record contents.SummaryDifference0.1%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.